Discounted Cash Flow (DCF) Analysis Levered

The Gabelli Healthcare & Wellness T... (GRX)

$9.99

-0.06 (-0.60%)
All numbers are in Millions, Currency in USD

Free Cash Flow

Year
A/P
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 25.01-----
Revenue (%)
Operating Cash Flow 45.24-----
Operating Cash Flow (%)
Capital Expenditure ------
Capital Expenditure (%)
Free Cash Flow ------

Weighted Average Cost Of Capital

Share price $ 9.99
Beta 1.065
Diluted Shares Outstanding 17.04
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 5.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity 8.724
Total Debt -
Total Equity 170.25
Total Capital 170.25
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash Flow

Year
A/P
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 25.01-----
Operating Cash Flow 45.24-----
Capital Expenditure ------
Free Cash Flow ------
WACC
PV LFCF -----
SUM PV LFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 8.72
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -0.01
Equity Value -
Shares Outstanding 17.04
Equity Value Per Share -